EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 107 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,155,318 | +21.2% | 1,145,847 | +32.0% | 0.00% | 0.0% |
| Q2 2023 | $7,551,278 | +177.5% | 867,963 | -6.2% | 0.00% | +100.0% |
| Q1 2023 | $2,721,311 | +35.5% | 925,616 | +61.3% | 0.00% | – |
| Q4 2022 | $2,008,608 | -44.7% | 573,888 | +24.9% | 0.00% | -100.0% |
| Q3 2022 | $3,633,000 | -56.4% | 459,372 | -56.6% | 0.00% | -50.0% |
| Q2 2022 | $8,335,000 | -54.3% | 1,059,117 | -29.5% | 0.00% | -50.0% |
| Q1 2022 | $18,241,000 | -3.0% | 1,501,296 | -2.3% | 0.00% | 0.0% |
| Q4 2021 | $18,799,000 | +81.2% | 1,535,913 | +54.3% | 0.00% | +100.0% |
| Q3 2021 | $10,372,000 | +10.9% | 995,324 | -4.3% | 0.00% | 0.0% |
| Q2 2021 | $9,349,000 | -17.5% | 1,039,785 | -6.8% | 0.00% | -33.3% |
| Q1 2021 | $11,337,000 | +12358.2% | 1,115,804 | +7940.7% | 0.00% | – |
| Q4 2020 | $91,000 | – | 13,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |